FDA authorizes Roche drug for severely ill COVID-19 patients
FDA authorizes Roche drug for severely ill COVID-19 patients
The Food and Drug Administration granted emergency approval to Roche’s Actemra (tocilizumab) to boost outcomes among hospitalized COVID-19 patients receiving oxygen and steroid medications.
via FOX NEWS https://ift.tt/3wXlK3U
Comments
Post a Comment
Please do not enter any spam link in comment box